Kenzie L Preston1, William J Kowalczyk2, Karran A Phillips2, Michelle L Jobes2, Massoud Vahabzadeh3, Jia-Ling Lin3, Mustapha Mezghanni3, David H Epstein2. 1. Clinical Pharmacology and Therapeutics Research Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, USA. kpreston@intra.nida.nih.gov. 2. Clinical Pharmacology and Therapeutics Research Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, USA. 3. Biomedical Informatics Section, Administrative Management Branch, Intramural Research Program, National Institute on Drug Abuse, 251 Bayview Blvd., Suite 200, Baltimore, MD, 21224, USA.
Abstract
RATIONALE: Knowing how stress manifests in the lives of people with substance-use disorders could help inform mobile "just in time" treatment. OBJECTIVES: The purpose of this paper is to examine discrete episodes of stress, as distinct from the fluctuations in background stress assessed in most EMA studies. METHODS: For up to 16 weeks, outpatients on opioid-agonist treatment carried smartphones on which they initiated an entry whenever they experienced a stressful event (SE) and when randomly prompted (RP) three times daily. Participants reported the severity of stress and craving and the context of the report (location, activities, companions). Decomposition of covariance was used to separate within-person from between-person effects; r effect sizes below are within-person. RESULTS: Participants (158 of 182; 87%) made 1787 stress-event entries. Craving for opioids increased with stress severity (r effect = 0.50). Stress events tended to occur in social company (with acquaintances, 0.63, friends, 0.17, or on the phone, 0.41) rather than with family (spouse, -0.14; child, -0.18), and in places with more overall activity (bars, 0.32; outside, 0.28; walking, 0.28) and more likelihood of unexpected experiences (with strangers, 0.17). Being on the internet was slightly protective (-0.22). Our prior finding that being at the workplace protects against background stress in our participants was partly supported in these stressful-event data. CONCLUSIONS: The contexts of specific stressful events differ from those we have seen in prior studies of ongoing background stress. However, both are associated with drug craving.
RATIONALE: Knowing how stress manifests in the lives of people with substance-use disorders could help inform mobile "just in time" treatment. OBJECTIVES: The purpose of this paper is to examine discrete episodes of stress, as distinct from the fluctuations in background stress assessed in most EMA studies. METHODS: For up to 16 weeks, outpatients on opioid-agonist treatment carried smartphones on which they initiated an entry whenever they experienced a stressful event (SE) and when randomly prompted (RP) three times daily. Participants reported the severity of stress and craving and the context of the report (location, activities, companions). Decomposition of covariance was used to separate within-person from between-person effects; r effect sizes below are within-person. RESULTS:Participants (158 of 182; 87%) made 1787 stress-event entries. Craving for opioids increased with stress severity (r effect = 0.50). Stress events tended to occur in social company (with acquaintances, 0.63, friends, 0.17, or on the phone, 0.41) rather than with family (spouse, -0.14; child, -0.18), and in places with more overall activity (bars, 0.32; outside, 0.28; walking, 0.28) and more likelihood of unexpected experiences (with strangers, 0.17). Being on the internet was slightly protective (-0.22). Our prior finding that being at the workplace protects against background stress in our participants was partly supported in these stressful-event data. CONCLUSIONS: The contexts of specific stressful events differ from those we have seen in prior studies of ongoing background stress. However, both are associated with drug craving.
Authors: Rajita Sinha; Makram Talih; Robert Malison; Ned Cooney; George M Anderson; Mary Jeanne Kreek Journal: Psychopharmacology (Berl) Date: 2003-07-04 Impact factor: 4.530
Authors: Gabriele Caselli; Antonella Gemelli; Sara Querci; Anna Maria Lugli; Flaviano Canfora; Claudio Annovi; Daniela Rebecchi; Giovanni M Ruggiero; Sandra Sassaroli; Marcantonio M Spada; Edward R Watkins Journal: Addict Behav Date: 2013-08-29 Impact factor: 3.913
Authors: Eric B Hekler; Susan Michie; Misha Pavel; Daniel E Rivera; Linda M Collins; Holly B Jimison; Claire Garnett; Skye Parral; Donna Spruijt-Metz Journal: Am J Prev Med Date: 2016-11 Impact factor: 5.043
Authors: Helen C Fox; Dongju Seo; Keri Tuit; Julie Hansen; Anne Kimmerling; Peter T Morgan; Rajita Sinha Journal: J Psychopharmacol Date: 2012-01-09 Impact factor: 4.153
Authors: David H Epstein; Matthew Tyburski; William J Kowalczyk; Albert J Burgess-Hull; Karran A Phillips; Brenda L Curtis; Kenzie L Preston Journal: NPJ Digit Med Date: 2020-03-04
Authors: Leigh V Panlilio; Samuel W Stull; William J Kowalczyk; Karran A Phillips; Jennifer R Schroeder; Jeremiah W Bertz; Massoud Vahabzadeh; Jia-Ling Lin; Mustapha Mezghanni; Edward V Nunes; David H Epstein; Kenzie L Preston Journal: Drug Alcohol Depend Date: 2019-07-16 Impact factor: 4.492
Authors: Kenzie L Preston; William J Kowalczyk; Karran A Phillips; Michelle L Jobes; Massoud Vahabzadeh; Jia-Ling Lin; Mustapha Mezghanni; David H Epstein Journal: Psychopharmacology (Berl) Date: 2018-07-07 Impact factor: 4.530
Authors: Robert Miranda; Stephanie E Wemm; Hayley Treloar Padovano; Ryan W Carpenter; Noah N Emery; Joshua C Gray; Ethan H Mereish Journal: Clin Psychol Sci Date: 2019-09-01
Authors: P Carrieri; C Baunez; E Giorla; S Nordmann; C Vielle; Y Pelloux; P Roux; C Protopopescu; C Manrique; K Davranche; C Montanari; L Giorgi; A Vilotitch; P Huguet Journal: Psychopharmacology (Berl) Date: 2022-01-11 Impact factor: 4.530
Authors: Landhing M Moran; William J Kowalczyk; Karran A Phillips; Massoud Vahabzadeh; Jia-Ling Lin; Mustapha Mezghanni; David H Epstein; Kenzie L Preston Journal: Am J Drug Alcohol Abuse Date: 2018-04-11 Impact factor: 3.829
Authors: Kenzie L Preston; Jennifer R Schroeder; William J Kowalczyk; Karran A Phillips; Michelle L Jobes; Megan Dwyer; Massoud Vahabzadeh; Jia-Ling Lin; Mustapha Mezghanni; David H Epstein Journal: Drug Alcohol Depend Date: 2018-10-11 Impact factor: 4.492